(Press-News.org)
Autism spectrum disorder (ASD) is a condition affecting the brain’s development and often affects the ability of a person to perceive sensory information and social cues and socialize with others. Recent studies have revealed that environmental factors and epigenetic processes, such as DNA methylation, are crucial to the development of ASD. Notably, immune activation and exposure to stress hormones are known to alter neuronal activity in the dorsal raphe (DR, a region of the brain involved in serotonin signaling), contributing to ASD development. Despite this, DNA methylation profiles of the DR in the context of ASD have not been investigated, leaving a critical gap in our understanding of the epigenetic regulation of this brain region and its association with ASD.
In a recent exploratory study, a research team from Japan, led by Professor Hideo Matsuzaki from the Research Center for Child Mental Development, University of Fukui, along with Dr. Keiko Iwata from the School of Pharmaceutical Sciences, Wakayama Medical University, conducted epigenetic profiling on postmortem brain samples of individuals with and without ASD to delve deeper and shed light on this issue. The findings of the study were published in Psychiatry and Clinical Neurosciences on April 24, 2025.
Epigenetic profiling is a process that analyzes chemical modifications on DNA that affect gene regulation. DNA strands can be tagged with chemical markers (like methyl groups), and while these tags don’t change the genetic code, they do control how genes are expressed. Using tools like the Infinium HumanMethylation450 BeadChip (Illumina) for DNA methylation profiling and qRT-PCR for gene expression analysis, the researchers conducted genome-wide DNA methylation analysis focused on the DR nucleus, previously under-explored in autism research. Additionally, they also conducted EM-amplicon sequencing to validate the site-specific methylation.
Interestingly, the results of this study revealed extensive DNA methylation abnormalities in the critical genomic regions. In addition, genes like OR2C3 (olfactory receptor gene) and HTR2C (serotonin receptor gene) showed hypermethylation (increase in DNA methylation activity) in ASD brain samples. These changes could be linked to the sensory processing differences and serotonin disruption in patients with ASD. Moreover, they observed hypomethylation in the promoter region of RABGGTB, a gene related to autophagy and synaptic function, which corresponds to its heightened expression.
Elaborating further on these findings, Prof. Matsuzaki says, “RABGGTB is an exciting discovery; it is absent from the current SFARI gene database (a major scientific resource focusing on genes associated with ASD), making it a truly novel candidate for autism.” Hinting at the potential of further exploring this gene candidate, he says, “Studying this gene could open new doors to understanding ASD, and perhaps even lead to a future diagnostic biomarker.”
Overall, this study sheds light on potential mechanisms underlying ASD, unlocking critical clues for its regulation and adding to the growing understanding of how epigenetic alterations affect neurodevelopmental disorders. Nonetheless, further studies are needed to combine DNA methylation profiling with transcriptome analysis and draw a relation between aberrant DNA methylation and RNA expression. Sharing his closing remarks on this study, Prof. Matsuzaki optimistically says, “Our study provides valuable insights into the molecular landscape of ASD, opening avenues for future diagnosis and therapeutic breakthroughs for autism.”
***
Reference
Title of original paper: Genome-wide DNA methylation profiles in the raphe nuclei of patients with autism spectrum disorder
Journal: Psychiatry and Clinical Neurosciences
DOI: 10.1111/pcn.13830
About University of Fukui, Japan
The University of Fukui is a preeminent research institution with robust undergraduate and graduate schools focusing on education, medical and science, engineering, and global and community studies. The university conducts cutting-edge research and strives to nurture human resources capable of contributing to society on the local, national, and global levels.
Website: https://www.u-fukui.ac.jp/eng/
About Professor Hideo Matsuzaki from University of Fukui, Japan
Dr. Hideo Matsuzaki is a neuroscientist and serves as a Professor and Center Director at the Research Center for Child Mental Development, University of Fukui, Japan. He obtained a Ph.D. in Medicine from Osaka University in 2003. His research integrates various disciplines to understand the pathophysiology of autism, including metabolic and lipidomic studies, neuroimaging and brain connectivity, analysis of environmental risk factors, and genetic and developmental mechanisms. With more than 120 publications and impactful collaborations, he continues to make significant contributions to the field of child mental health.
Funding information
This study was supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K. I. (19K08041 and 23K07019) and a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H. M. (19H03581).
END
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the meta-analysis of data from the PROTECTED TAVR and BHF PROTECT TAVI Trials
Background
The embolisation of debris after transaortic valve implantation (TAVI) for the treatment of aortic stenosis can lead to stroke. Cerebral embolic protection (CEP) devices, which can capture this debris and thus lower the incidence of stroke, have been deployed during ...
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the FAITAVI randomised clinical trial (RCT).
Background
The optimal management of patients with intermediate coronary artery disease (CAD) and severe aortic stenosis (AS) who are candidates for TAVI remains unclear. Recent trials comparing percutaneous coronary intervention ...
Background
While dual antiplatelet therapy (DAPT) has long been the standard of care for the management of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), there is an increasing awareness of the need to find a more patient-centred approach that strikes a balance between the ischaemic protection DAPT offers and the risk of bleeding complications it can create.
The effect of DAPT in dosage and duration on cardiovascular events and bleeding after implantation of drug-coated stents (DCS) in ACS patients, ...
Research Highlights:
The American Heart Association’s PREVENTTM risk calculator accurately identified participants who had calcium buildup in their heart arteries and those who had a higher future heart attack risk, in an analysis of about 7,000 adults in New York City referred for heart disease screening.
The PREVENT scores also predicted future heart attack risk.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, May 21, 2025
DALLAS, May 21, 2025 — The PREVENTTM risk calculator helped to identify people with plaque buildup in the arteries of the heart, in addition to predicting their risk of a future heart attack, according ...
Researchers at the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, have developed a new, easily manufacturable solid-state thermoelectric refrigeration technology with nano-engineered materials that is twice as efficient as devices made with commercially available bulk thermoelectric materials. As global demand grows for more energy-efficient, reliable and compact cooling solutions, this advancement offers a scalable alternative to traditional compressor-based refrigeration.
In a paper published in ...
Researchers at the Francis Crick Institute have shown that gonadotrophs, cells in the pituitary gland with a key role in puberty and reproduction, come from two different populations, with the majority produced after birth rather than in the embryo, as previously thought.
A better understanding of when these important cells develop could help researchers and clinicians understand and treat disorders that impact puberty and fertility.
In the pituitary, a small gland located in the middle of the head and connected to the brain, gonadotrophs ...
By carefully placing nanostructures on a flat surface, researchers at Linköping University, Sweden, have significantly improved the performance of so-called optical metasurfaces in conductive plastics. This is a major step for controllable flat optics, with future applications such as video holograms, invisibility materials, and sensors, as well as in biomedical imaging. The study has been published in the journal Nature Communications.
To control light, curved lenses are used today, that are often made of glass that is either concave or convex, ...
Halving the number of times vital signs and neurological function are checked in low-risk patients after treatment for acute ischaemic stroke does not compromise care or recovery, according to new findings presented at the 11th European Stroke Organisation Conference in Helsinki, Finland.
Results from the Optimal Post rTpa-Iv Monitoring in Ischaemic Stroke Trial (OPTIMISTmain)1, simultaneously published in The Lancet, also showed that this approach also had flow-on benefits for nursing workflow and intensive care resources. The trial was led by Professor Craig Anderson from The George Institute for Global Health and UNSW ...
External walls of buildings are normally lifeless and have no additional function. An international team of researchers and companies, in which Carole Planchette from the Institute of Fluid Mechanics and Heat Transfer is involved, wants to change this by adding microbial life to building façades. In the project “Archibiome tattoo for resistant, responsive, and resilient cities” (REMEDY), the consortium is working on integrating specifically composed communities of beneficial microorganisms into ...
New research in rats indicates that a Mediterranean plant may be an effective treatment for ulcerative colitis, a type of inflammatory bowel disease. The findings are published in the Journal of the Science of Food and Agriculture.
Various antioxidant and anti-inflammatory medications are used to treat ulcerative colitis, but they can cause numerous side effects. To test the potential of the Arbutus unedo plant (often referred to as the strawberry tree) that is native to the Mediterranean region, investigators gave rats doses of an extract from the plant ...
